Case Study: Keryx Biopharmaceuticals achieves rapid, compliant FDA product launch readiness with Veeva Systems' Commercial Cloud

Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch

Keryx Biopharmaceuticals, preparing to launch its first FDA‑approved product Auryxia, needed to rapidly build a commercial foundation that supported sales and marketing, enabled business agility, and could scale without the burden of legacy systems.

Keryx implemented Veeva Commercial Cloud — including Veeva CRM (with Approved Email and CLM), Vault PromoMats, and Veeva Network — to centralize customer data, compliant content, and multichannel interactions. The solution let Keryx stand up its commercial infrastructure quickly and cost‑effectively, speed MLR approvals and content distribution, provide a single customer view for synchronized sales and marketing, and support ongoing growth and agility.

Keryx

Abraham Ceesay

Vice President of Marketing and Operations